Joint Oxford Cancer Immuno-Oncology Network/Oxford Immunology Network seminar in targeted immunotherapies, followed by networking coffee

15:00-15:30 Dr Pedro Durao, “Targeting transcription elongation to modulate the immune surveillance of emergent prostate cancer’”, followed by Q&A
15:30-16:00 Dr Felipe Galvez-Cancino, “Treg targeting reprograms the innate and adaptive immune microenvironment in glioblastoma”, followed by Q&A
16:00 Networking coffee